Amphastar Pharmaceuticals experienced a dip, but long-term i...
Amphastar Pharmaceuticals experienced a dip, but long-term its performance is strong due to profitability transition and faster EPS growth versus share price. However, market growth expectations are moderated. Share price momentum indicates a potential investment opportunity.
Those Who Invested in Amphastar Pharmaceuticals (NASDAQ:AMPH) Five Years Ago Are up 166%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment